Cancer & Infectious Disease Focus Fuels Adjuvant R&D Boom

adicionou um novo artigo Health

2025-06-16 09:33:15

Valued at US $3.81 billion in 2024, the Vaccine Adjuvants Market is gaining prominence in global health. With a projected CAGR of 4.3%, the market is on track to reach US $4.86 billion by 2030, powered by advancements in vaccine technologies and a growing emphasis on public immunization. View the Executive Summary Free Market Drivers & Growth Catalysts 1. Rising Infectious Disease...

0 Comentários 0 Compartilhamentos 26 Visualizações 0 Anterior